Methods 41 patients with malignant pleural effusion were treated by Lifein.
方法41例恶性胸腔积液患者应用力尔凡的腔内给药治疗。
Objective: To summary and analyze the present treatment of malignant pleural effusion.
前言：目的：总结分析恶性胸腔积液目前的治疗方法。
Results: the specific CT signs of malignant pleural effusion shown the pleura thickening clearly.
结果：恶性胸腔积液的特征性CT表现为胸膜的明显增厚。
Objective: To study the efficacy of KLT by intrapleural injection in treating malignant pleural effusion.
目的：探讨康莱特(KLT)腔内注射对恶性胸腔积液治疗的价值。
NGF is effective in the treatment for malignant pleural effusion and can improve patients' quality of life.
恩格菲治疗恶性胸水有效，可提高患者生存质量。
Objective To raise the diagnosis level of tuberculous pleural effusion (TPE) and malignant pleural effusion (MPE).
目的提高结核性胸腔积液(TPE)与恶性胸腔积液(MPE)的诊断水平。
It's reported in many articles that aneuploids are observed in the chromosomes of malignant pleural effusion cells.
多数文献报告，在恶性胸腔积液中，细胞染色体可呈非整倍体性。
Objective to explore the value of center vein catheter thoracostomy in the chemotherapy of malignant pleural effusion.
目的探讨胸腔内置入单腔中心静脉导管化疗对恶性胸腔积液的价值。
Malignant pleural effusion can severely affect the function of respiration and circulation and increase the patient's death.
恶性胸腔积液能严重影响病人的呼吸循环功能，加速病人死亡。
Conclusion The LDH can be used as an indicator to distinguish tuberculosis pleural effusion from malignant pleural effusions.
结论胸水中LDH检测对区别结核性与癌性胸水有帮助。
Conclusion KLT can effective treat malignant pleural effusion enhance immune function prolong living time improve life quality.
结论康莱特能有效地控制恶性胸腔积液，提高免疫力，延长生存期，改善生活质量。
Therapy of HAS can effectively control the malignant pleural effusion and improve the life quality of the lung cancer patients.
在全身化疗的基础上，高聚金葡素胸腔内注射能有效控制肺癌恶性胸水，提高生存质量。
The end stage of lung adenocarcinoma is often associated with distant metastasis and formation of malignant pleural effusion (PE).
肺腺癌早期症状不明显且不易察觉，但末期常并发远端转移及恶性肋膜腔积水。
Many methods and markers have been used in the diagnosis of malignant pleural effusion, with different advantages and disadvantages.
许多方法和指标都曾尝试用于恶性胸腔积液的诊断，各有利弊。
The surface configuration of pulmonary adenocarcinoma cells in the malignant pleural effusion of 15 patients was investigated with SEM.
用扫描电镜观察15例胸水肺腺癌细胞表面超微结构。
Delisheng injection treatment in lung cancer patients with malignant pleural effusion was safe and effective, it is worth further study.
结论得力生注射液治疗肺癌恶性胸腔积液安全有效，值得进一步研究。
AIM: To evaluate the efficacy and safety on the radio-heating-chemotherapy in treatment of patients with malignant pleural effusion (MPE).
目的：为了改善晚期肿瘤患者生活质量，观察局部射频透热化疗治疗恶性胸腔积液患者的临床疗效。
Conclusion: Injection of combination of IL2 and cisplatin is effective in treating malignant pleural effusion, and the side effect is minor.
结论：胸腔内注入顺铂联合白介素2治疗恶性胸腔积液疗效好，且毒副反应小。
The cases with malignant pleural effusion were effectively controlled the occurrence of pleural effusion by injection of chemotherapy drugs.
对恶性胸腔积液患者行腔内注入化疗药物后有效控制胸腔积液的发生。
Results LDH in the patients with tuberculosis pleural effusion was significantly lower than that in patients with malignant pleural effusion.
结果结核性胸水患者LDH明最低于癌性胸水患者。
Conclusions Medical thoracoscope not only has accurate diagnostic value but also has effective treatment effect for malignant pleural effusion.
目的探讨经内科胸腔镜多部位胸膜钳夹对恶性胸腔积液的诊治价值。
Methods: To assay the activity of ADA in specimen and serum between the patients of 156 tuberculous pleural effusions and 60 malignant pleural effusion.
方法：对156例结核性胸腔积液和60例恶性胸腔积液标本进行腺苷脱氨酶测定，同时测定血清腺苷脱氨酶活性。
This paper provides evidence that IL-17 secreting CD4 t (TH17) cells are present in the malignant pleural effusion (MPE) of cancer patients. So are TH1.
该研究提供的证据显示癌症患者的恶性胸腔积液(MPE)中可以观察到产生白介素- 17的CD 4T (TH17)细胞以及TH 1细胞。
AIM: to observe the clinical efficacy of Nocardia rubra cell wall skeleton (n CWS) in the treatment of malignant pleural effusion by intrapleural injection.
目的：观察红色诺卡菌细胞壁骨架(NCWS)胸腔内注射治疗恶性胸腔积液的临床疗效。
Purpose:The CT features of malignant pleural effusion have been discussed. The value of CT in the diagnosis of malignant pleural effusion were also described.
前言： 目的：探讨恶性胸腔积液的CT表现特点，及CT在恶性胸腔积液诊断中的应用价值。
Objective: To observe the diagnostic value of VEGF, CD44V6, MMP2, MMP9 and their combined examination in distinguishing malignant pleural effusion from benign one.
目的：探讨CD 44 V 6、VEGF、MMP2、MMP9单项和联合检测在良恶性胸腔积液性质鉴别诊断中的价值。
Objective: To observe the diagnostic value of VEGF, CD44V6, MMP2, MMP9 and their combined examination in distinguishing malignant pleural effusion from benign one.
目的：探讨CD 44 V 6、VEGF、MMP2、MMP9单项和联合检测在良恶性胸腔积液性质鉴别诊断中的价值。
应用推荐